Imagine a future where cancer surgeries are so precise that patients rarely need follow-up operations. That future might be closer than you think. The cornerstone of cancer treatment is surgical removal of tumors, but ensuring all cancerous tissue is gone while preserving healthy tissue is a delicate balance. Surgeons currently rely on pre-surgery imaging and post-surgery pathology, a process that can lead to repeat surgeries for up to one-third of breast cancer patients. But here's where it gets groundbreaking: Caltech's Lihong Wang has developed a revolutionary technique called ultraviolet photoacoustic microscopy (UV-PAM) that could change the game entirely.
Traditional pathology is a time-consuming process. Tissue samples must be stabilized, sliced, stained, and examined under a microscope—a procedure that can take hours or even days. This delay not only prolongs patient anxiety but also increases the likelihood of additional surgeries if cancer cells are found at the margins of the excised tissue. And this is the part most people miss: the reliance on human pathologists introduces variability, making standardized results challenging to achieve.
Wang’s UV-PAM technique bypasses these limitations entirely. Instead of freezing or chemically fixing tissue, UV-PAM uses a low-energy laser to excite the tissue, leveraging the natural absorption properties of DNA and RNA. This process creates a contrast between cell nuclei and surrounding tissue, eliminating the need for staining. The tissue’s vibration in response to the laser generates ultrasonic waves, producing high-resolution images with precision down to 200–300 nanometers. Artificial intelligence (AI) then enhances these images to mimic traditional hematoxylin and eosin (H&E) staining, ensuring familiarity for pathologists and surgeons.
But here's where it gets controversial: While UV-PAM promises faster, more accurate results, some may argue that relying on AI for diagnosis could undermine the expertise of human pathologists. However, Wang emphasizes that AI acts as a tool to augment, not replace, human judgment. By analyzing images in real-time, AI can provide immediate feedback, allowing surgeons to make informed decisions during the operation itself. With an analysis time of under 10 minutes, UV-PAM could significantly reduce the need for repeat surgeries.
The technique’s versatility is another game-changer. Currently, it appears to work equally well on breast, bone, skin, and organ tissues, making it a potentially universal tool in cancer surgery. And this is the part that sparks debate: If widely adopted, could UV-PAM render traditional pathology methods obsolete? Or will it coexist as a complementary technology?
Published in Science Advances on November 21, 2025, this research is still in its testing phase. However, Wang and his team are optimistic about its commercial potential. With funding from the National Institutes of Health and the National Research Foundation of Korea, the path to clinical application seems promising.
What do you think? Could UV-PAM revolutionize cancer surgery, or are there hurdles we’re not yet considering? Share your thoughts in the comments below!
